The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
silence therapeutics | 29 |
atugen | 4 |
quark pharmaceuticals | 3 |
quark biotech | 1 |
silence therapeutics | 42 |
quark pharmaceuticals | 5 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
interfering rna molecules | 58 | 2002 |
further use of protein kinase n beta | 31 | 2002 |
therapeutic uses of inhibitors of rtp801 | 29 | 2004 |
lipids, lipid complexes and use thereof | 27 | 2004 |
means for inhibiting the expression of protein kinase 3 | 18 | 2006 |
lipid complexes coated with peg and their use | 16 | 2004 |
therapeutic uses of inhibitors of rtp801 | 16 | 2006 |
factor involved in metastasis and uses thereof | 14 | 2002 |
lipoplex formulations for specific delivery to vascular endothelium | 10 | 2006 |
means for lung specific delivery | 8 | 2013 |